Zobrazeno 1 - 10
of 34
pro vyhledávání: '"J. Abu-Jawad"'
Autor:
C. Pöttgen, E. Gkika, M. Stahl, J. Abu Jawad, T. Gauler, S. Kasper, T. Trarbach, K. Herrmann, N. Lehmann, K.-H. Jöckel, H. Lax, M. Stuschke
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-11 (2021)
Abstract Background This prospective phase I/II trial assessed feasibility and efficacy of dose-escalated definitive chemoradiation after induction chemotherapy in locally advanced esophageal cancer. Primary study endpoint was loco-regional progressi
Externí odkaz:
https://doaj.org/article/edc024d5b20f4786b0500b21739305fc
Autor:
Hildegard Lax, Michael Stahl, Ken Herrmann, J. Abu Jawad, Karl-Heinz Jöckel, Nils Lehmann, Thomas Gauler, Christoph Pöttgen, Tanja Trarbach, Martin Stuschke, Stefan Kasper, Eleni Gkika
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-11 (2021)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background This prospective phase I/II trial assessed feasibility and efficacy of dose-escalated definitive chemoradiation after induction chemotherapy in locally advanced esophageal cancer. Primary study endpoint was loco-regional progression-free s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eed7e0f2c2cff9dddc1a008e1e9f3cf
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85103170583
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85103170583
Autor:
Stephan Lang, N. Rothmeier, Diana Arweiler-Harbeck, Judith Arnolds, Stefan Mattheis, S. Zander, J. Abu-Jawad, Nina Dominas, R. Stein
Hintergrund: Wundheilungsstorungen und chronische Wunden konnen ein Problem nach Radiatio darstellen. Sie treten spontan oder nach weiteren chirurgischen Masnahmen auf. Durch die radiogen veranderte Gewebebeschaffenheit werden rezidivierende bakterie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df43d8f5465c21b1e24465052e28fdd3
https://www.ncbi.nlm.nih.gov/pubmed/25152972
https://www.ncbi.nlm.nih.gov/pubmed/25152972
Autor:
Maja Guberina, Thomas Gauler, Christoph Pöttgen, J. Abu Jawad, Martin Stuschke, Wilfried Eberhardt, Georgios Stamatis, A. Bockisch
Publikováno v:
Radiotherapy and Oncology. 115:S327-S328
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1602a3978fdc7ea7af7e6d5e724e5e
https://doi.org/10.1016/s0167-8140(15)40662-0
https://doi.org/10.1016/s0167-8140(15)40662-0
Autor:
J. Abu Jawad, B. Graupner, Dirk Theegarten, Lutz Freitag, Stefan Welter, Martin Stuschke, Wilfried Eberhardt, Christoph Pöttgen, Thomas Gauler, Jeremias Wohlschlaeger, Georgios Stamatis
Radiation dose escalation within definitive radiochemotherapy (RTx/CTx) was not successful for stage III non-small cell lung cancer (NSCLC) using conventional fractionation (CF). Accelerated-hyperfractionation (AHF) counteracts tumour cell repopulati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c42f8f9bf2ddab380299067791ab13a
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=84877687331
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=84877687331
Autor:
Martin Stuschke, Wilfried Eberhardt, J. Abu Jawad, Katharina Berkovic, Eleni Gkika, C. Poettgen, Thomas Gauler
Materials/Methods: Pts with stage III NSCLC treated at a large cancer center 1997-2009 with radical radiation (RT) (50Gy or more) (+/chemo), but no surgery, were retrospectively identified. Pt, tumor and treatment characteristics were extracted from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f1c7c45abd9a8abf024848cc750b29f
Autor:
Wolfgang Lübcke, Thomas Gauler, Georgios Stamatis, Eleni Gkika, Christoph Pöttgen, Martin Stuschke, J. Abu Jawad, Wilfried Eberhardt
Publikováno v:
Radiotherapy and Oncology. 111:S46-S47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42d956fe41f15f5d3bf54b88c1eea62f
https://doi.org/10.1016/s0167-8140(15)31293-7
https://doi.org/10.1016/s0167-8140(15)31293-7
Autor:
J. Abu-Jawad, S. Ting, J. Markowetz, Sven Brandau, M. Schuler, I. Vossebein, Stefan Kasper, Stephan Lang, Thomas Gauler, Christoph Bergmann, Michael Pogorzelski, K.W. Schmid, F. Breitenbücher, Sandra Hoffarth
Publikováno v:
Oral Oncology. 51:e39
Introduction Monoclonal antibodies and tyrosine kinase inhibitors (TKI) targeting the EGFR are approved or under investigation for the systemic treatment of patients with HNSCC. However, primary and acquired resistance against EGFR-targeted therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ffaa652330cb466ba61e50982d1b6bb
https://doi.org/10.1016/j.oraloncology.2015.02.040
https://doi.org/10.1016/j.oraloncology.2015.02.040
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.